In 2020, the global infusion therapy market size was valued at around $7.5 billion, which is a 15% decrease when compared to 2019. In spite of COVID19, the global market size is expected to increase over the forecast period and reach $11.2 billion in 2027. Currently, the majority of the global infusion therapy market share is controlled by three main companies – Becton Dickinson, B. Braun, and ICU Medical.

Infusion therapy devices represent an integral and basic component of many treatment plans. As such, the improving quality and access to healthcare worldwide stand to positively affect the global market throughout the next 6 years. Many of the global regions have large populations that currently cannot effectively access healthcare treatment. As this continues to improve, this analysis projects how the demand for infusion therapy products will impact the global market size in 2021 and beyond.

Most countries worldwide still use gravity drip infusion more often than pump-based infusion. However, this is slowly expected to shift as sales of all varieties of infusion pumps continue to grow in many regions, including Europe. Infusion pumps offer many benefits over gravity infusions, such as increased safety features and more precise control over the treatment process. The main drawbacks are higher costs and increased need for clinician training. However, as patient volumes increase, the time and money invested into increasing the total usage of pump infusion are expected to be a justifiable expense.

How Many Intravenous Sets Are Sold Globally?

Globally, there are over 5.9 billion intravenous sets sold every year, with the Asia Pacific selling the largest number of units.Intravenous (IV) sets are devices that consist of a length of tubing that is used to administer a solution directly into the patient’s veins. This is also known as infusion therapy, and it is mostly used when oral therapy is deemed not a viable option. The number of IV sets sold will increase dramatically over the next 6 years, allowing the global intravenous set market to reach over $10 billion in 2027.

How’s COVID19 Impacting The Infusion Therapy Market?

The global infusion therapy market was impacted significantly by the global COVID-19 pandemic throughout 2020. As infection rates increased around the globe, many facilities saw declines in elective procedures and certain other visits. This decreased the overall demand for basic healthcare products, including infusion therapy devices.

In particular, the market for infusion pumps was severely impacted due to many facilities restricting their budgets and not being able to justify the replacement of pre-existing pumps while the current devices were still functional. The global market is expected to continue to be affected to a lesser degree throughout 2021, and this study project the COVID19 impact based on the worst-case and best-case scenarios.

What Are the Top Infusion Therapy Companies?

Over 50% of the global infusion therapy market share is controlled by three main companies – Becton Dickinson, B. Braun, and ICU Medical.

Becton Dickinson (BD) is the leading player in the global market for infusion therapy devices. The company has been the market leader since its 2015 acquisition of CareFusion, from which it acquired all of its infusion therapy products. Becton Dickinson is involved in all of the individual infusion therapy market segments and leads the markets for IV sets and needleless connectors.

B. Braun is the second-leading competitor in the global infusion therapy device market. The company narrowly led the infusion pump segment over Becton Dickinson, and it was second overall within IV sets. B. Braun also leads the market for stopcocks by a narrow margin over BD, while holding a notable share of the needleless connector market.

ICU medical is the third-leading competitor in the global market. The company strengthened its presence in the IV therapy device market by acquiring Hospira in 2017. Currently, ICU Medical has a strong presence in the infusion pump, IV set, needleless connector, and IV stopcock device markets.

Market Segmentation Summary

While this global report suite contains all global infusion therapy market data, each of the market segments is also available as a stand-alone report, MedCore. This allows you to get access to only the infusion therapy market research that you need.

• Infusion Pumps Market | Global | 2021-2027 | MedCore – The market analysis is further broken down into segments by:
  • Device Type: Large Volume Pumps, Syringe Pumps, Patient-Controlled Analgesia Pumps, Electronic Ambulatory Pumps, and Disposable Ambulatory Pumps.

• IV Sets Market | Global | 2021-2027 | MedCore – The chapter contains the market analysis which is categorized by:
  • Set Type: Pump Sets, Gravity Set, Extension Sets, and Secondary Sets.

• Needleless Connectors Market | Global | 2021-2027 | MedCore – The market is broken down by:
  • Valve Type: Split Septum, Blunt Cannula, and Mechanical Valves;

• Stopcocks Market | Global | 2021-2027 | MedCore – The research includes an in-depth analysis of the global stopcock market;

• Blood Transfusion Sets Market | Global | 2021-2027 | MedCore – The research ONLY provides a top-level analysis of the blood transfusion set market.

Global Research Scope Summary

CONTACT US FOR ADDITIONAL INFORMATION

For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
 

FREE Sample Report